lopinavir/ritonavir, Drugs Monitor, Page 3

(27 April 2020) Update on clinical studies of key drug molecules for COVID 19

April 28, 2020

Update on treatment of COVID-19: ongoing studies between promising and disappointing results. https://www.ncbi.nlm.nih.gov/pubmed/32335561 A compilation of results of trials going on (up to April 15, 2020)for key molecules used in treatment of COVID-19 is presented. Data for Chloroquine, hydroxychloroquine, remdesevir,… Continue reading "(27 April 2020) Update on clinical studies of key drug molecules for COVID 19"

(18 March 2020) Lopinavir+Ritonavir- Early clinical outcomes

Lopinavir+ Ritonavir- Secondary outcomes of study show some benefits https://www.nejm.org/doi/full/10.1056/NEJMoa2001282 Cao et al. carried out a randomized, controlled, open-label trial for lopinavir–ritonavir (ritonavir helps to stabilize lopinavir) in 199 hospitalized patients with severe COVID-19, of whom 99 were assigned to… Continue reading

Tag: lopinavir/ritonavir

(27 April 2020) Update on clinical studies of key drug molecules for COVID 19

(18 March 2020) Lopinavir+Ritonavir- Early clinical outcomes